Trustmark National Bank Trust Department’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5M | Buy |
29,741
+2,110
| +8% | +$354K | 0.35% | 65 |
|
2025
Q1 | $3.81M | Buy |
27,631
+4,150
| +18% | +$572K | 0.28% | 71 |
|
2024
Q4 | $2.78M | Buy |
23,481
+1,068
| +5% | +$126K | 0.21% | 90 |
|
2024
Q3 | $2.48M | Buy |
22,413
+279
| +1% | +$30.8K | 0.19% | 94 |
|
2024
Q2 | $2.18M | Sell |
22,134
-1,357
| -6% | -$133K | 0.17% | 100 |
|
2024
Q1 | $2.63M | Buy |
23,491
+1,159
| +5% | +$130K | 0.21% | 93 |
|
2023
Q4 | $2.25M | Buy |
22,332
+1,504
| +7% | +$152K | 0.2% | 94 |
|
2023
Q3 | $1.81M | Buy |
20,828
+3,888
| +23% | +$338K | 0.18% | 98 |
|
2023
Q2 | $1.6M | Buy |
16,940
+297
| +2% | +$28.1K | 0.15% | 114 |
|
2023
Q1 | $1.26M | Buy |
16,643
+8,986
| +117% | +$678K | 0.11% | 129 |
|
2022
Q4 | $589K | Buy |
7,657
+904
| +13% | +$69.5K | 0.05% | 172 |
|
2022
Q3 | $450K | Buy |
+6,753
| New | +$450K | 0.04% | 192 |
|
2016
Q4 | – | Sell |
-3,895
| Closed | -$303K | – | 250 |
|
2016
Q3 | $303K | Sell |
3,895
-327
| -8% | -$25.4K | 0.04% | 213 |
|
2016
Q2 | $330K | Sell |
4,222
-1,658
| -28% | -$130K | 0.04% | 217 |
|
2016
Q1 | $482K | Buy |
5,880
+659
| +13% | +$54K | 0.07% | 180 |
|
2015
Q4 | $466K | Buy |
5,221
+149
| +3% | +$13.3K | 0.06% | 200 |
|
2015
Q3 | $389K | Buy |
5,072
+190
| +4% | +$14.6K | 0.05% | 229 |
|
2015
Q2 | $409K | Sell |
4,882
-1
| -0% | -$84 | 0.05% | 228 |
|
2015
Q1 | $441K | Buy |
4,883
+892
| +22% | +$80.6K | 0.06% | 233 |
|
2014
Q4 | $322K | Sell |
3,991
-3,914
| -50% | -$316K | 0.04% | 246 |
|
2014
Q3 | $591K | Buy |
7,905
+11
| +0.1% | +$822 | 0.08% | 199 |
|
2014
Q2 | $541K | Sell |
7,894
-4,001
| -34% | -$274K | 0.06% | 214 |
|
2014
Q1 | $832K | Hold |
11,895
| – | – | 0.1% | 177 |
|
2013
Q4 | $794K | Buy |
11,895
+2,314
| +24% | +$154K | 0.09% | 171 |
|
2013
Q3 | $500K | Hold |
9,581
| – | – | 0.06% | 211 |
|
2013
Q2 | $452K | Buy |
+9,581
| New | +$452K | 0.06% | 215 |
|